The Australian Medical Association Limited and state AMA entities comply with the Privacy Act 1988. Please refer to the AMA Privacy Policy to understand our commitment to you and information on how we store and protect your data.



22 Mar 2018

A recent study published in the International Journal of Clinical Pharmacy found that pharmacists have a valuable role to play in detecting and resolving drug related problems as part of the general practice team. The AMA has long advocated for the incorporation of non-dispensing pharmacists into general practices to improve medication management, educate patients and to support GP prescribing, a model that would improve patient care and deliver significant savings to the Australian health system.

The study, Pharmacists in general practice: a focus on drug‑related problems, surveyed a number of general practices in Western Sydney. It was conducted over 6 months using 493 patient consultations. This research demonstrates a model for how pharmacists can be integrated into the general practice team and shows that GPs are willing to collaborate with pharmacists in team-based primary care.

In 2015 the AMA released a proposal calling on the Commonwealth to establish a funding program to support general practices to employ pharmacists - the Pharmacist in General Practice Incentive Program (PGPIP). Supported by independent economic analysis, the AMA model outlined how pharmacists could assist GPs to deliver:

  • Better coordination of patient care;
  • Improved prescribing;
  • Improved medication use;
  • Reduced medication-related problems;
  • Fewer adverse drug events (ADEs);
  • Fewer hospital admissions (from reduced ADEs); and
  • Improved health outcomes for patients, including a better quality of life.

To read more about the AMA’s position, click here.

Published: 22 Mar 2018